James J. Ryan
Cambridge, ENG CB21RY, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Impact of Market Access Delays on Time to Patient Access: Multi-Country Comparative Analysis Assessing the First Commercial Launch Indications for Five Oncology Medicines Across Europe and Canada.
Journal: Journal of market access & health policy
Published: January 09, 2026
The role of patient-reported outcomes in health technology assessments: global practices and future implications.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 18, 2025
EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-Making.
Journal: Journal of market access & health policy
Published: June 30, 2025
Patient Preferences in Neoadjuvant Therapy for HER2+ Early-Stage Breast Cancer.
Journal: MDM policy & practice
Published: January 31, 2025
Technology Assessment vs. Technology Appraisal-How to Strengthen the Science/Value Dichotomy with EU HTA?
Journal: Journal of market access & health policy
Published: August 27, 2024
Evaluation of the EMA log kow trigger for fish BCF testing based on data for several human pharmaceuticals.
Journal: Regulatory toxicology and pharmacology : RTP
Published: March 15, 2024
Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes.
Journal: Journal of medical economics
Published: December 05, 2023
The Impact of Additive Population(s), Intervention, Comparator(s), and Outcomes in a European Joint Clinical Health Technology Assessment.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 16, 2023
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.
Journal: Journal of market access & health policy
Published: October 11, 2023
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder pre-convention questionnaire.
Journal: Journal of market access & health policy
Published: June 07, 2023
Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC Study.
Journal: Current therapeutic research, clinical and experimental
Published: April 15, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026